Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Aurobindo Pharma has been rallying from Rs 150 onwards when there was a correction; it has doubled itself. Stocks have been known to double and then redouble themselves. So, I would not say that Aurobindo Pharma’s rally is a bubble at all."
He further added, "Orchid Chemicals has to be taken in context. There was enormous decline in stock prices; that decline is over. The bear market is over. This is probably the beginning of a new bull market for this stock. It is not going to be easy. However, there is a buy on dips opportunity here also. Today we don’t want to buy anything, but the stocks are worth looking at and they will offer opportunities for gains if you buy them at corrections."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!